In the News
Complying with lab data integrity practices during COVID-19
PPD’s John Maier discusses how accelerated startup and overall timelines of COVID-19 trials have presented a significant challenge to ensuring compliance with lab data integrity regulations.
Facilitating adoptive cell therapy clinical trials
PPD’s Panteli Theocharous and Fiona Thistlethwaite of The Christie NHS Foundation Trust discuss both the site and CRO role to improve the patient journey through the clinical development process, as well as the patient and product process pathway from initial referral through to follow-up.
Viral safety testing: Keeping the fly out of the ointment
PPD’s Panteli Theocharous and Patrick Bennett comment on the evolving nature of gene therapies.
The importance of CROs during the pandemic
PPD instrumental in the success of Moderna’s COVID-19 vaccine study
The NC company winning praise with Moderna’s positive Covid vaccine data
PPD recognized for its role in the development of the important vaccine.
PPD lands praise from partner Moderna which reports strong results for COVID-19 vaccine
PPD’s 25 years of vaccine development experience essential to the successful execution of the study.
Training Isn’t a Drive-Thru
Amy Chapman explains that responding to a training request doesn’t need to be treated like a fast food order.
Advanced therapies: Navigation and application of EU and U.S. guidelines during product development
Kirsten Messmer and Richard Dennett provide a high-level overview and navigation guide through the multitude of available advanced therapy guidance in the EU and U.S.
Viral Vector API Characterization of Product-Related Impurities
A team of PPD® Laboratories scientists reviews existing analytical applications, focusing on viral vector characterization of impurities.